"Bone Resorption" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Bone loss due to osteoclastic activity.
| Descriptor ID |
D001862
|
| MeSH Number(s) |
C05.116.264 G11.427.213.150
|
| Concept/Terms |
Bone Resorption- Bone Resorption
- Bone Resorptions
- Resorption, Bone
- Resorptions, Bone
- Osteoclastic Bone Loss
- Bone Loss, Osteoclastic
- Bone Losses, Osteoclastic
- Loss, Osteoclastic Bone
- Losses, Osteoclastic Bone
- Osteoclastic Bone Losses
|
Below are MeSH descriptors whose meaning is more general than "Bone Resorption".
Below are MeSH descriptors whose meaning is more specific than "Bone Resorption".
This graph shows the total number of publications written about "Bone Resorption" by people in this website by year, and whether "Bone Resorption" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 3 | 4 |
| 2005 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 1 | 0 | 1 |
| 2013 | 2 | 2 | 4 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 1 | 3 |
| 2019 | 1 | 2 | 3 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2024 | 2 | 2 | 4 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Resorption" by people in Profiles.
-
Brain tumors induce widespread disruption of calvarial bone and alteration of skull marrow immune landscape. Nat Neurosci. 2025 Nov; 28(11):2231-2246.
-
Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects. Bone Res. 2024 Sep 05; 12(1):52.
-
Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial. Nat Med. 2024 Sep; 30(9):2605-2612.
-
Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss. Cell. 2024 Jul 11; 187(14):3690-3711.e19.
-
Murine IRF8 Mutation Offers New Insight into Osteoclast and Root Resorption. J Dent Res. 2024 03; 103(3):318-328.
-
Post-antibiotic gut dysbiosis-induced trabecular bone loss is dependent on lymphocytes. Bone. 2020 05; 134:115269.
-
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease. Sci Transl Med. 2019 05 29; 11(494).
-
Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption. J Bone Miner Res. 2019 04; 34(4):681-698.
-
Sympathetic ?1-adrenergic signaling contributes to regulation of human bone metabolism. J Clin Invest. 2018 11 01; 128(11):4832-4842.
-
BMPRIA is required for osteogenic differentiation and RANKL expression in adult bone marrow mesenchymal stromal cells. Sci Rep. 2018 05 31; 8(1):8475.